Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 243

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Effects of Lactobacillus casei supplementation on disease activity and inflammatory cytokines in rheumatoid arthritis patients: a randomized double‐blind clinical trial

Alipour, Beitullah, Homayouni‐Rad, Aziz, Vaghef‐Mehrabany, Elnaz, Sharif, Sakineh Khatoun, Vaghef‐Mehrabany, Leila, Asghari‐Jafarabadi, Mohammad, Nakhjavani, Mohammad Reza, Mohtadi‐Nia, Javad·2014·International Journal of Rheumatic Diseases

Abstract

Aim: The present study aimed at investigating the effects of Lactobacillus casei 01 supplementation on symptoms and inflammatory biomarkers of rheumatoid arthritis (RA) in women. Method: In this randomized double‐blind clinical trial, female patients with established RA for more than 1 year, 20–80 years of age and body mass index (BMI) lower than 40, who followed stable medication for 3 months prior to the supplementation, were randomly allocated to receive either one capsule containing 10 8 colony forming units (CFU) of L. casei 01, or a placebo for 8 weeks; allocation was stratified by BMI and menopausal status. Disease activity score‐28 (DAS 28) was calculated, European League Against Rheumatism (EULAR) response was evaluated and the cytokines, interleukin (IL)‐1β, IL‐6, IL‐10, IL‐12 and tumor necrosis factor (TNF)‐α were measured. Results: Thirty patients were recruited in each group; 22 and 24 patients were analyzed in the probiotic and placebo groups, respectively. L. casei 01 supplementation decreased serum high‐sensitivity C‐reactive protein (hs‐CRP) levels, tender and swollen joint counts, global health (GH) score and DAS 28 (P < 0.05). More patients in the L. casei 01 group had moderate response to the treatment, based on the EULAR criteria, at the end of the study (P < 0.01). At the end of the study, a significant difference was observed between the two groups for IL‐10, IL‐12 and TNF‐α changes through the study course (P < 0.05), in favor of the probiotic group. No adverse effects were reported for the intervention. Conclusion: Probiotic supplementation may be an appropriate adjunct therapy for RA patients and help alleviate symptoms and improve inflammatory cytokines.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/1756-185x.12333

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 243

Metadata

Authors
Alipour, B., Homayouni‐Rad, A., Vaghef‐Mehrabany, E., Sharif, S. K., Vaghef‐Mehrabany, L., Asghari‐Jafarabadi, M., Nakhjavani, M. R., & Mohtadi‐Nia, J.
Venue
International Journal of Rheumatic Diseases
Publisher
Wiley
Published
2014-03-27
Volume
17
Issue
5
Pages
519-527
ISSN
  • 1756-1841 (ISSN-L)
  • 1756-185X
OpenAlex
W2052020987
Cited by
243
References
2
FWCI
19.57
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of Lactobacillus casei supplementation on disease activity and inflammatory cytokines in rheumatoid arthritis patients: a randomized double‐blind clinical trial. https://app.cochat.ai/papers/10.1111/1756-185x.12333
The paper
Alipour, B., Homayouni‐Rad, A., Vaghef‐Mehrabany, E., Sharif, S. K., Vaghef‐Mehrabany, L., Asghari‐Jafarabadi, M., Nakhjavani, M. R., & Mohtadi‐Nia, J. (2014). Effects of Lactobacillus casei supplementation on disease activity and inflammatory cytokines in rheumatoid arthritis patients: a randomized double‐blind clinical trial. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.12333

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.